| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Stewart Sell | |
| Hyam L Leffert | |||
| P2860 | cites work | Identifying cancer stem cells in solid tumors: case not proven | Q82606186 |
| Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma | Q24680119 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Significance of CD90+ cancer stem cells in human liver cancer | Q28266933 | ||
| Heterogeneity and plasticity of hepatocyte lineage cells | Q32076111 | ||
| Stem cell origin of cancer and differentiation therapy | Q33203952 | ||
| Most C6 cells are cancer stem cells: evidence from clonal and population analyses | Q33282339 | ||
| Somatic stem cells and the kinetics of mutagenesis and carcinogenesis | Q34075155 | ||
| Immature hepatic tumor of bimodal differentiation in a young adult patient: a novel lesion expressing beta-catenin and mimicking a distinct phase of hepatogenesis | Q34307429 | ||
| Cancer stem cells: an old idea--a paradigm shift | Q34495973 | ||
| Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line | Q34544440 | ||
| Cellular origin of hepatocellular carcinomas | Q35018040 | ||
| Cancer and the immortal strand hypothesis | Q35175933 | ||
| ETHIONINE CARCINOGENESIS. | Q35443086 | ||
| Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures | Q35585322 | ||
| Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury | Q35677684 | ||
| Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma | Q35757248 | ||
| Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver | Q35885290 | ||
| Cancer stem cells and differentiation therapy | Q36430045 | ||
| Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin si | Q36499888 | ||
| Ultrastructural localisation of alpha-fetoprotin (AFP) in regenerating mouse liver poisoned with CCL4. 1. Reexpression of AFP in differentiated hepatocytes | Q36592474 | ||
| Potential gene therapy strategies for cancer stem cells | Q36638513 | ||
| Leukemia: stem cells, maturation arrest, and differentiation therapy | Q36672139 | ||
| Genomics and signaling pathways in hepatocellular carcinoma. | Q36733952 | ||
| The relation of mesenchymal cell products to hepatic epithelial systems | Q37874492 | ||
| Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation | Q38186098 | ||
| Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture | Q38593507 | ||
| Recent trends in cancer biochemistry: the importance of studies on fetal tissue. | Q39905245 | ||
| EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma | Q40006245 | ||
| Identification of local and circulating cancer stem cells in human liver cancer | Q40013131 | ||
| Cell population dynamics in the liver. A review of quantitative morphological techniques applied to the study of physiological and pathological growth | Q40071446 | ||
| CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. | Q40076996 | ||
| The present status of the blocked ontogeny hypothesis of neoplasia: the thalassemia connection. | Q40101732 | ||
| Identification and characterization of tumorigenic liver cancer stem/progenitor cells | Q40119609 | ||
| Neoplastic progression in experimental hepatocarcinogenesis. | Q40198501 | ||
| Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties | Q40262786 | ||
| Ductular reaction in the liver | Q40370388 | ||
| Hepatic neoplasia: reflections and ruminations | Q40408295 | ||
| Tumour stem cells: the biological concept and its application in cancer treatment | Q40737136 | ||
| The hepatitis-associated bile duct lesion. | Q40808359 | ||
| Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. | Q40811485 | ||
| DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival | Q41100664 | ||
| Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma | Q41224812 | ||
| Sequential cellular changes during chemical carcinogenesis | Q41597686 | ||
| Ultrastructural characteristics of novel epithelial cell types identified in human pathologic liver specimens with chronic ductular reaction | Q42461117 | ||
| Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. | Q42839188 | ||
| Expression of c-kit protooncogene in human hepatocellular carcinoma | Q44375456 | ||
| Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells | Q44555699 | ||
| Mouse hepatoblastomas: a histologic, ultrastructural, and immunohistochemical study | Q44901518 | ||
| Aldolase isozymes in rat tumor cells | Q45265118 | ||
| Occurrence of oval-type cells in hepatitis B virus—associated human hepatocarcinogenesis | Q45881606 | ||
| A CD133-expressing murine liver oval cell population with bilineage potential | Q46285754 | ||
| Wnt/beta-catenin signaling mediates oval cell response in rodents | Q46955919 | ||
| Identification of bipotential progenitor cells in human liver regeneration. | Q52199249 | ||
| Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. | Q52277112 | ||
| Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. | Q52580893 | ||
| Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogens. | Q53562004 | ||
| The natural history of neoplastic development:The relation of experimental models to human cancer | Q53566032 | ||
| Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation. A study of 70 cases collected in Japan. | Q54153629 | ||
| Cancer stem cells in radiation resistance. | Q55467719 | ||
| The development of proliferating ductular structures in liver disease. An immunohistochemical study | Q67656344 | ||
| Analysis of cell cycle compartments of hepatocytes after partial hepatecomy | Q68208590 | ||
| Malignant mouse-liver tumors resembling human hepatoblastomas | Q68673707 | ||
| Relationship of rat alpha 1-fetoprotein to growth rate and chromosome composition of Morris hepatomas | Q68683705 | ||
| Primary malignant hepatic tumours in childhood | Q68944052 | ||
| Intrasplenic hepatocyte transplantation in rats with experimental liver injury: morphological and morphometric studies | Q69788777 | ||
| 'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver | Q71327876 | ||
| The nature and origin of proliferated bile ductules in alcoholic liver disease | Q71675184 | ||
| On the concept of minimum deviation in the study of the biochemistry of cancer | Q72063900 | ||
| Tumour stem cells: facts, interpretation and consequences | Q72352949 | ||
| Abnormal bile duct epithelium in liver biopsies with histological signs of viral hepatitis | Q72537181 | ||
| An Evaluation of Cellular Lineages in the Pathogenesis of Experimental Hepatocellular Carcinoma | Q72654281 | ||
| Aldolase isozymes in cancer | Q72915322 | ||
| The canals of Hering and hepatic stem cells in humans | Q73208585 | ||
| Small epithelial cells in extrahepatic biliary atresia: electron microscopic and immunoelectron microscopic findings suggest a close relationship to liver progenitor cells | Q73231897 | ||
| Characterization of ductular hepatocytes in primary liver allograft failure | Q73246545 | ||
| Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene | Q73928635 | ||
| Acute carbon tetrachloride hepatic injury; composite histological, histochemical and biochemical study. I. Histological and histochemical studies | Q73952732 | ||
| Comparison of liver progenitor cells in human atypical ductular reactions with those seen in experimental models of liver injury | Q74172246 | ||
| Histochemical studies of mouse liver after single feeding of carbon tetrachloride | Q75450561 | ||
| Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man | Q77386873 | ||
| A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3 | Q79401133 | ||
| Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver | Q79839838 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver cancer | Q623031 |
| neoplastic stem cells | Q1638475 | ||
| P304 | page(s) | 2800-2805 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Liver cancer stem cells | |
| P478 | volume | 26 |
| Q90862936 | A Survey of Molecular Heterogeneity in Hepatocellular Carcinoma |
| Q48718249 | A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. |
| Q53250439 | A model of liver carcinogenesis originating from hepatic progenitor cells with accumulation of genetic alterations. |
| Q30599952 | A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules. |
| Q36529938 | A rare case of adult hepatoblastoma with neuroendocrine differentiation misdiagnosed as neuroendocrine tumor |
| Q28834514 | Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease |
| Q42060696 | Age dependence of oval cell responses and bile duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, ethionine-supplemented diet |
| Q36591967 | Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation |
| Q53588249 | Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). |
| Q37666618 | Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? |
| Q52716307 | Anticancer Profiling for Coumarins and Related O-Naphthoquinones from Mansonia gagei against Solid Tumor Cells In Vitro. |
| Q92514832 | Ataxia telangiectasia mutated pathway disruption affects hepatic DNA and tissue damage in nonalcoholic fatty liver disease |
| Q34165885 | Beta-catenin signaling in hepatic development and progenitors: which way does the WNT blow? |
| Q34630557 | Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. |
| Q53255002 | CD13: Waving the flag for a novel cancer stem cell target. |
| Q36793453 | Cancer stem cells in the development of liver cancer |
| Q38023238 | Cancer stem cells, microRNAs, and therapeutic strategies including natural products |
| Q37621777 | Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis |
| Q41216714 | Cancer stem cells: repair gone awry? |
| Q47109220 | Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers |
| Q33601533 | Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma |
| Q47755684 | Characterization of liver injury, oval cell proliferation and cholangiocarcinogenesis in glutathione S-transferase A3 knockout mice |
| Q48118614 | Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance |
| Q52612153 | Comparison of protein expression between human livers and the hepatic cell lines HepG2, Hep3B, and Huh7 using SWATH and MRM-HR proteomics: Focusing on drug-metabolizing enzymes. |
| Q28242740 | DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival |
| Q26741205 | Diabetes mellitus and metformin in hepatocellular carcinoma |
| Q34962165 | Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B. |
| Q35048411 | Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells |
| Q90088319 | Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats |
| Q41621841 | Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma |
| Q58551580 | Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study |
| Q64977821 | Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms. |
| Q37581334 | Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives |
| Q53149182 | Evaluation of in vivo antioxidant and immunity enhancing activities of sodium aescinate injection liquid. |
| Q39847276 | Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice |
| Q37462365 | Experimental models of hepatocellular carcinoma: developments and evolution |
| Q39633080 | Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells |
| Q38890621 | Expression of Tight Junction Components in Hepatocyte-Like Cells Differentiated from Human Embryonic Stem Cells. |
| Q35048239 | Functional analysis of microRNAs in human hepatocellular cancer stem cells |
| Q35092061 | Hepatic progenitor cells express SerpinB3 |
| Q26823828 | Hepatic progenitor cells in canine and feline medicine: potential for regenerative strategies |
| Q45363162 | Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice |
| Q33737707 | Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation |
| Q28587974 | Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver |
| Q39762235 | Human cancer classification: a systems biology- based model integrating morphology, cancer stem cells, proteomics, and genomics |
| Q35985007 | Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer |
| Q37131434 | Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes |
| Q36400904 | Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. |
| Q33588191 | Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling |
| Q37891875 | Immunotherapy of prostate cancer: should we be targeting stem cells and EMT? |
| Q28550411 | Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma |
| Q34983695 | Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells |
| Q35581775 | Isolation of CD133+ liver stem cells for clonal expansion |
| Q34167953 | Knockdown of caveolin-1 by siRNA inhibits the transformation of mouse hepatoma H22 cells in vitro and in vivo |
| Q24653755 | Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression |
| Q37889223 | Liver development and cancer formation in zebrafish. |
| Q37695098 | Liver development, regeneration, and carcinogenesis |
| Q84972300 | Liver stem/progenitor cells in the canals of Hering: cellular origin of hepatocellular carcinoma with bile duct tumor thrombi? |
| Q34138074 | Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. |
| Q33777662 | MicroRNAs involved in neoplastic transformation of liver cancer stem cells |
| Q33872467 | Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation. |
| Q38163594 | Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study. |
| Q38552153 | Model systems and clinical applications of hepatic stem cells for liver regeneration |
| Q35260040 | Molecular mechanisms underlying hepatocellular carcinoma |
| Q33725172 | Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells |
| Q43245419 | Moving targets in hepatocellular carcinoma: hepatic progenitor cells as novel targets for tyrosine kinase inhibitors |
| Q92332162 | Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway |
| Q34069370 | Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver |
| Q37867484 | Notch signalling in solid tumours: a little bit of everything but not all the time |
| Q64279538 | O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E |
| Q92990507 | Obesity and the Risk of Gastrointestinal Cancers |
| Q37578671 | Oleanolic acid and ursolic acid inhibit proliferation in transformed rat hepatic oval cells |
| Q37739713 | On the stem cell origin of cancer |
| Q47815920 | Overexpression of Dickkopf 3 in hepatoblastomas and hepatocellular carcinomas |
| Q26771232 | Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis |
| Q36501666 | Pathophysiology of ocular surface squamous neoplasia |
| Q28384799 | Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cells |
| Q38770037 | Portal Vein Embolization with Contralateral Application of Stem Cells Facilitates Increase of Future Liver Remnant Volume in Patients with Liver Metastases |
| Q49679382 | Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma. |
| Q38089206 | Preclinical development of cancer stem cell drugs |
| Q92462428 | Preclinical verification of the efficacy by targeting peptide-linked liposomal nanoparticles for hepatocellular carcinoma therapy |
| Q39844138 | Primary isolated hepatic oval cells maintain progenitor cell phenotypes after two-year prolonged cultivation |
| Q26998435 | Prostate Cancer Stem Cells: Research Advances |
| Q43506762 | Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice. |
| Q38150408 | Regenerative toxicology: the role of stem cells in the development of chronic toxicities |
| Q33940403 | Role of Wnt/β-catenin signaling in liver metabolism and cancer |
| Q34259112 | Role of liver stem cells in hepatocarcinogenesis |
| Q39044754 | Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells |
| Q33931154 | Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines |
| Q26863580 | Targeting the Notch signaling pathway in cancer therapeutics |
| Q37677914 | The Fox genes in the liver: from organogenesis to functional integration |
| Q53308300 | The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma. |
| Q37134143 | The controversial clinicobiological role of breast cancer stem cells |
| Q37940376 | The proteomics of cancer stem cells: potential clinical applications for innovative research in oncology |
| Q33925732 | The role of stem cells in liver repair and fibrosis |
| Q36941050 | Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice. |
| Q37132646 | Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. |
| Q34924005 | Upregulated microRNA-92b regulates the differentiation and proliferation of EpCAM-positive fetal liver cells by targeting C/EBPß. |
| Q38836415 | iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells |
| Q92192259 | miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway |
| Q38987401 | p53 on the crossroad between regeneration and cancer |
| Q42716243 | p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells |
| Q38993024 | β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma |
Search more.